Novel biaromatic compounds which activate receptors of PPAR type and their use in cosmetic or pharmaceutical compositions

Details for Australian Patent Application No. 2005274277 (hide)

Owner Galderma Research & Development, S.N.C.

Inventors Boiteau, Jean-Guy; Clary, Laurence

Agent Griffith Hack

Pub. Number AU-A-2005274277

PCT Pub. Number WO2006/018325

Priority 60/607,782 08.09.04 US; 04/08932 17.08.04 FR

Filing date 12 August 2005

Wipo publication date 23 February 2006

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 17/00 (2006.01) Drugs for dermatological disorders

C07C 233/87 (2006.01) Carboxylic acid amides

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/018325 Priority application(s): WO2006/018325

23 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274278-Novel biaromatic compounds that activate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions

2005274266-Immune stimulatory infant nutrition